Novo Nordisk A/S: Johannesburg joins Cities Changing Diabetes
(Thomson Reuters ONE) -
Bagsværd, Denmark, Friday 8 April 2016 - Today, the city of Johannesburg joins
the Cities Changing Diabetes programme and becomes the first African city to
join the global initiative. The addition of the largest city in South Africa as
a partner city means Cities Changing Diabetes now brings together six cities
across four continents in the fight against urban diabetes.
Johannesburg City Member of the Mayoral Council on Health and Social Development
Ms Nonceba Molwele says: "Diabetes is ranked 6(th) among the top 10 leading
causes of death in Johannesburg and represents a significant public health
challenge here. Joining Cities Changing Diabetes is an exciting opportunity for
us to learn more about what we can do to combat this growing condition. We look
forward to learning from the experiences of other cities around the world, so
that we can create a more liveable and healthy Johannesburg with fewer people at
risk of developing diabetes."
Cities Changing Diabetes was established in 2014 by founding partners Novo
Nordisk, University College London (UCL) and Steno Diabetes Center. The
programme aims to tackle the rise of diabetes in cities through three distinct
but interconnecting phases: mapping, sharing and action.
In November 2015, the partnership presented findings of first-of-its-kind
research that found that diabetes vulnerability in cities is linked to a complex
mix of social and cultural factors(1)- responsible for both putting people at
greater initial risk of developing type 2 diabetes and subsequently making them
less likely to be diagnosed, receive treatment and maintain good health. For
example the study findings showed that in Houston many people link diabetes with
lower socio-economic status, while people of all economic classes are in fact
vulnerable to the condition. In Mexico City, gender roles were linked to
increased diabetes vulnerability among women, who sometimes went undiagnosed
after neglecting their personal health.
Global research lead David Napier, professor of Medical Anthropology, UCL
explains: "We are helping cities to look beyond traditional biomedical risk
factors for diabetes to consider why it is that urban inhabitants are at
increased risk of diabetes. Working with Johannesburg is significant for the
programme as it will provide our first insights into urban diabetes in Africa
and crucially, will enable the city to take action for the health of its
citizens."
The programme insights have already informed a decision in February 2016 by
Cities Changing Diabetes partner city Copenhagen to establish a new diabetes
centre. The centre will enable improved access to diabetes for all citizens
including care for vulnerable, hard-to-reach populations identified by the
programme's research efforts. In addition to Johannesburg, Houston, Mexico City
and Copenhagen, the cities of Shanghai and Tianjin are sharing insights and
taking action as part of the Cities Changing Diabetes programme.
About Cities Changing Diabetes
Cities Changing Diabetes is a partnership programme to address the urban
diabetes challenge. Initiated by Novo Nordisk, the programme is a response to
the dramatic rise of urban diabetes and has been developed in partnership with
University College London and Steno Diabetes Center, as well as a range of local
partners including the diabetes/health community, city governments, academic
institutions, city experts (from a variety of fields) and civil society
organisations. To date, the following cities are partners of the programme:
Mexico City, Houston, Copenhagen, Shanghai, Tianjin and Johannesburg. The aim of
the programme is to map the problem, share solutions and drive concrete action
to fight the diabetes challenge in the big cities around the world. For more
information, visit citieschangingdiabetes.com
Further information
Media:
Katrine Sperling +45 4442 6718 krsp(at)novonordisk.com
Ken Inchausti (US) +1 609 786 8316 kiau(at)novonordisk.com
Investors:
Peter Hugreffe Ankersen +45 3075 9085 phak(at)novonordisk.com
Daniel Bohsen +45 3079 6376 dabo(at)novonordisk.com
Melanie Raouzeos +45 3075 3479 mrz(at)novonordisk.com
Kasper Veje +45 3079 8519 kpvj(at)novonordisk.com
1. Data on file, Cities Changing Diabetes
Read the press release:
http://hugin.info/2013/R/2001638/738571.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Novo Nordisk A/S via GlobeNewswire
[HUG#2001638]
Unternehmensinformation / Kurzprofil:
Datum: 08.04.2016 - 08:41 Uhr
Sprache: Deutsch
News-ID 462763
Anzahl Zeichen: 5499
contact information:
Town:
Bagsvaerd
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 252 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Novo Nordisk A/S: Johannesburg joins Cities Changing Diabetes"
steht unter der journalistisch-redaktionellen Verantwortung von
Novo Nordisk A/S (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
